
Akụkọ kacha ọhụrụ: IL-4 na-eme ka ike ọgwụgwụ nke mkpụrụ ndụ CD8+ CART

Akụkọ| Mgbakwunye-n'ịkọwa mkpokọta mpaghara nwere ike ịkpata adịghị arụ ọrụ cell CAR-T

Usoro Sanger vs. Usoro ọgbọ na-abịa (NGS)
Alpha Lifetech Incorporation na-agbanwegharị ngalaba nke teknụzụ biotechnology site na ịnye ọrụ mgbago elu na mgbada ala ahaziri maka protein ndị na-emegharị ahụ. Site n'ilekwasị anya n'iwepụta akụrụngwa protein dị elu, Alpha Lifetech bu n'obi ịhazi nyocha na usoro mmepe maka ụlọ ọrụ biopharmaceutical. Site n'inye ihe ngwọta ọhụrụ nke na-egbo mkpa ụlọ ọrụ ahụ kpọmkwem, ụlọ ọrụ ahụ na-ahụ maka mmepụta nke ọma na ịdị ọcha nke protein. Ebumnuche a na-akwalite ikike nke ndị ọkà mmụta sayensị na ndị nyocha na ọkwa Alpha Lifetech dị ka onye ndu na ngalaba biotechnology. Site na ntinye aka n'ịkwalite teknụzụ protein, Alpha Lifetech Incorporation dị njikere inye aka dị ukwuu na ọganihu sayensị na mmepe ọgwụgwọ.

Ntuziaka zuru oke maka ihicha protein: Ụzọ, usoro, na ngwa
Alpha Lifetech Incorporation ekwupụtala nyocha zuru oke nke ịdị ọcha protein, nzọụkwụ dị mkpa na usoro mmepụta protein. Ntụleghachi ahụ na-enye nghọta ndị bụ isi na isi ihe dị mkpa maka nyocha na nyocha na-esote na ngalaba nke ịdị ọcha protein. A na-atụ anya na nlebanya a ga-enye aka dị ukwuu n'ọganihu nke mmepụta protein na mmepe nke ebumnuche ọgwụgwọ ọhụrụ. A maara Alpha Lifetech Incorporation maka nka ya n'ichepụta biopharmaceutical ma na-agba mbọ ịnye ihe ngwọta dị mma maka ịdị ọcha protein. A na-atụ anya nyocha a ka ọ nwee mmetụta dị ukwuu na ụlọ ọrụ ahụ ma mee ka ọnọdụ Alpha Lifetech sie ike dị ka onye ndu na nyocha na mmepe biopharmaceutical.

Akụkọ kacha ọhụrụ| Nnyocha ọhụrụ na-egosi na ọ nwere ike igbanwe mbibi ọrịa kansa
Na June 1, 2024, na akwụkwọ akụkọ Nature Communications, ndị ọkà mmụta sayensị sitere na ndị otu nyocha Bo Li bipụtara otu isiokwu akpọrọ "Area postrema neurons mediate interleukin-6 function in cancer cachexia". Akụkọ ahụ chọpụtara na mmụba nke interleukin-6 nwere ike ibute arụ ọrụ ụbụrụ yana n'ikpeazụ cachexia cancer.

Akụkọ kacha ọhụrụ | Onye mmechi nke mbụ n'ime klas nke EGFR na PI3K na-enye ụzọ otu-molecule maka ịchedo nguzogide mmegide.
Na July 11, 2024, otu ndị nchọpụta nke Dr. Judith Sebolt Leopold na-eduzi haziri kinase inhibitor MTX-531 nke nwere ike igbochi epidermal growth factor receptor (EGFR) na phosphatidylinositol 3-OH kinase (PI3K).

Jiri ọgwụ mgbochi biosimilar mee ka nchọpụta ọgwụ mee ngwa ngwa - Ngwa ngwa ngwa ijikọ ejikọta
Alfa Lifetech's 700+ biosimilar antibodies lekwasịrị anya EGFR, TNF-α, VEGF, na-eme ka nyocha ọgwụ na-eme ngwa ngwa n'ịdị mma akwadoro.

Imeghe ihe omimi nke usoro ndu: Alpha Lifetech na-ewepụta protein protein dị elu maka ndị sayensị.
Alpha Lifetech na-enye protein akpụkpọ anụ dị mma maka nchọpụta ọgwụ yana nghọta cellular, na-eji usoro mmepụta dị elu.

Nkà na Sayensị nke Nchọpụta Nanobody: ka Alpha Lifetech si na-akwagide ókèala
Chọpụta teknụzụ nanobody: ngosipụta phage, ọgwụ mgbochi, nyocha, nhọrọ, na nyocha nhazi na Alpha Lifetech maka nyocha na ọgwụgwọ.